01 / RESEARCH SUMMARY
GHK-Cu/KPV Blend Research Summary
Research blend combining GHK-Cu with the anti-inflammatory tripeptide KPV. Studied for skin remodeling, immune modulation, and tissue repair.
Read the full guide →02 / DOSING & RECONSTITUTION
Dosing & Reconstitution Guide
Human dosing is not established.
The calculator is a pure mass-and-volume math tool. Generic inputs are not compound-specific vial sizes or preparation instructions; IU, weight-based, percentage and ready-made solution ranges are not converted into mg doses.
Human dosing is not established.
Blend components: GHK-Cu, KPV. Combined safety and dosing are not established.
03 / RECONSTITUTION CALCULATOR
Mix & measure GHK-Cu/KPV Blend · 5 mg
Generic mass-and-volume inputs only — enter your own values. No compound-specific dose or preparation is recommended.
- CONCENTRATION
- 2.50 mg/mL
- DRAW VOLUME
- — mL
- ON THE SYRINGE
- — units
- DOSES / VIAL
- —
Reconstitution math only. U-100 syringe: 100 units = 1 mL.
Reconstitution GuideFull calculator →04 / STORAGE
Storage Instructions
No compound-specific storage or preparation instructions were supplied. Follow the exact formulation's documented requirements.
05 / RESEARCH FINDINGS
What Research Shows
Unvalidated blend
- Collagen synthesis and skin elasticity
- Reduced inflammation
- Wound healing support
- Immune modulation
Research context
Combined safety and dosing are not established.
06 / MOLECULAR BIOLOGY
Mechanism of Action
Supplied research description
Proposed research targets
Research blend combining GHK-Cu with the anti-inflammatory tripeptide KPV. Studied for skin remodeling, immune modulation, and tissue repair.
Adamantane & the blood–brain barrier
Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.
07 / STUDIES
Studies & references
08 / SAFETY
Safety considerations
- Verify the active identity, lot number, and matching certificate of analysis. Testing does not by itself establish sterility or suitability for human use.
- Follow documented product-specific storage and preparation requirements; stability and diluent compatibility depend on the formulation.
- Research powders are not interchangeable with prescription formulations. Do not infer an injection or nasal protocol from a concentration calculation.
- For medical care, pregnancy, existing conditions, or medication interactions, consult a qualified healthcare professional.
09 / RECOMMENDED SOURCE
Recommended Source
Not currently carried by Orbitrex.
Compare research suppliers →